Free Access
Issue
J Extra Corpor Technol
Volume 49, Number 1, March 2017
Page(s) 49 - 53
DOI https://doi.org/10.1051/ject/201749049
Published online 15 March 2017
  1. Nikolaidis N., Velissaris T., Ohru S. K. Bivalirudin anticoagulation for cardiopulmonary bypass: An unusual case. Tex Heart Inst J. 2000;34:115–8. [Google Scholar]
  2. Warkentin T. E., Greinacher A., Koster A. Bivalirudin. Thromb Haemost. 2008;99:830–9. [Google Scholar]
  3. Federman M., Dragomer D., Grant S., Reemsten B., Biniwale R. Use of bivalirudin for anticoagulation during implantation of total artificial heart. J Extra Corpor Technol. 2014;46:170–2. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Baker T., Chan R., Hill F. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant. J Extra Corpor Technol. 2004;36:371–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Zucker M. L., Koster A., Prats J., LaDuca F. M. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Technol. 2005;37:364–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Gordon G., Rastegar H., Schumann R., Denman W. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasci Anesth. 2003;17:632–5. [CrossRef] [Google Scholar]
  7. McNair E., Marcoux J. A., Bally C., Gamble J., Thomson D. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery. Perfusion. 2016;31:189–99. [CrossRef] [PubMed] [Google Scholar]
  8. Garland C., Somogyi D. Successful implantation of a left ventricular assist device in a patient with heparin-induced thrombocytopenia and thrombosis. J Extra Corpor Technol. 2014;46:162–5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Pfohler C., Muller C. S. L., Pindur G., et al. Delayed-type heparin allergy: Diagnostic procedures and treatment—A case series including 15 patients. World Allergy Organ J. 2008;1:194–9. [CrossRef] [Google Scholar]
  10. Ahmed I., Majeed A., Powell R. Heparin induced thrombocytopenia: Diagnosis and management update. Postgrad Med J. 2007;83:575–82. [CrossRef] [PubMed] [Google Scholar]
  11. Veale J. J., McCarthy H. M., Palmer G., Dyke C. M. Use of bivalrudin as an anticoagulant during cardiopulmonary bypass. J Extra Corpor Technol. 2005;37:296–302. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Measday M. A., Zucker M. L., Pan C. M., LaDuca F. M. Optimizing management of hirudin anticoagulation. J Extra Corpor Technol. 2005;37:66–70. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.